Matthew Parker

17.7k total citations
23 papers, 1.0k citations indexed

About

Matthew Parker is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Matthew Parker has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Matthew Parker's work include SARS-CoV-2 and COVID-19 Research (6 papers), Tuberculosis Research and Epidemiology (3 papers) and Respiratory viral infections research (3 papers). Matthew Parker is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Tuberculosis Research and Epidemiology (3 papers) and Respiratory viral infections research (3 papers). Matthew Parker collaborates with scholars based in United States, United Kingdom and Australia. Matthew Parker's co-authors include Jinghui Zhang, Randall Reves, Alan M. Copenhaver, Sunny Shin, Naomi H. Philip, Baofeng Hu, Elizabeth A. Mauldin, Lei Wei, Douglas R. Green and Christopher P. Dillon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Matthew Parker

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Parker United States 15 444 284 212 194 154 23 1.0k
Furen Zhang China 19 213 0.5× 307 1.1× 290 1.4× 157 0.8× 445 2.9× 118 1.5k
Zifen Gao China 19 425 1.0× 366 1.3× 381 1.8× 46 0.2× 237 1.5× 52 1.2k
Yi Wei China 18 441 1.0× 658 2.3× 78 0.4× 139 0.7× 363 2.4× 35 1.6k
Rebecca A. Porritt United States 17 357 0.8× 386 1.4× 159 0.8× 412 2.1× 344 2.2× 25 1.2k
Weimin Zhou China 17 262 0.6× 378 1.3× 177 0.8× 106 0.5× 67 0.4× 54 1.1k
Haisheng Yu China 22 440 1.0× 219 0.8× 289 1.4× 115 0.6× 633 4.1× 54 1.3k
Takafumi Fukui Japan 17 295 0.7× 230 0.8× 466 2.2× 91 0.5× 41 0.3× 50 1.1k
Isabel Rodrı́guez Spain 21 532 1.2× 104 0.4× 235 1.1× 157 0.8× 124 0.8× 76 1.5k
Catherine Do United States 23 634 1.4× 62 0.2× 114 0.5× 171 0.9× 230 1.5× 49 1.5k

Countries citing papers authored by Matthew Parker

Since Specialization
Citations

This map shows the geographic impact of Matthew Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Parker more than expected).

Fields of papers citing papers by Matthew Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Parker. The network helps show where Matthew Parker may publish in the future.

Co-authorship network of co-authors of Matthew Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Parker. A scholar is included among the top collaborators of Matthew Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Parker. Matthew Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asante, Ivy Asantewaa, Sharon Hsu, John Kofi Odoom, et al.. (2023). Repurposing an integrated national influenza platform for genomic surveillance of SARS-CoV-2 in Ghana: a molecular epidemiological analysis. The Lancet Global Health. 11(7). e1075–e1085. 5 indexed citations
2.
Jeewandara, Chandima, Deshni Jayathilaka, Sharon Hsu, et al.. (2021). Genomic and Epidemiological Analysis of SARS-CoV-2 Viruses in Sri Lanka. Frontiers in Microbiology. 12. 722838–722838. 8 indexed citations
3.
Leary, Shay, Silvana Gaudieri, Matthew Parker, et al.. (2021). Generation of a Novel SARS-CoV-2 Sub-genomic RNA Due to the R203K/G204R Variant in Nucleocapsid: Homologous Recombination has Potential to Change SARS-CoV-2 at Both Protein and RNA Level. SHILAP Revista de lepidopterología. 6(2). 27–49. 43 indexed citations
4.
Stirrup, Oliver, Joseph Hughes, Matthew Parker, et al.. (2021). Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data. eLife. 10. 19 indexed citations
5.
Shepheard, Stephanie, Matthew Parker, Johnathan Cooper‐Knock, et al.. (2021). Value of systematic genetic screening of patients with amyotrophic lateral sclerosis. Journal of Neurology Neurosurgery & Psychiatry. 92(5). 510–518. 70 indexed citations
6.
Pang, Juanita, Justin Penner, Matthew Parker, et al.. (2021). Evolution of viral variants in remdesivir‐treated and untreated SARS‐CoV‐2‐infected pediatrics patients. Journal of Medical Virology. 94(1). 161–172. 14 indexed citations
7.
8.
Harding‐Esch, Emma M., Sebastian Fuller, Achyuta Nori, et al.. (2018). Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation. Clinical Microbiology and Infection. 25(3). 380.e1–380.e7. 15 indexed citations
9.
Caulfield, Mark J., Jim Davies, Tom Fowler, et al.. (2017). The 100,000 Genomes Project Protocol. Figshare. 32 indexed citations
10.
Wei, Lei, Brian L. Murphy, Gang Wu, et al.. (2017). Exome sequencing analysis of murine medulloblastoma models identifies WDR11 as a potential tumor suppressor in Group 3 tumors. Oncotarget. 8(39). 64685–64697. 6 indexed citations
11.
Harding‐Esch, Emma M., Sebastian Fuller, Christine S. Chow, et al.. (2016). Performance of a prototype chlamydia and gonorrhoea recombinase polymerase amplification point-of-care test in three sexual health clinics. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 1 indexed citations
12.
Valentin-Vega, Yasmine A., Yong‐Dong Wang, Matthew Parker, et al.. (2016). Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation. Scientific Reports. 6(1). 25996–25996. 116 indexed citations
13.
DeCoteau, William E., Karin L. Heckman, Ana Y. Estevez, et al.. (2016). Cerium oxide nanoparticles with antioxidant properties ameliorate strength and prolong life in mouse model of amyotrophic lateral sclerosis. Nanomedicine Nanotechnology Biology and Medicine. 12(8). 2311–2320. 67 indexed citations
14.
Parker, Matthew & Heather F. Smith. (2016). Anatomical variation in the anterolateral ligament of the knee and a new dissection technique for embalmed cadaveric specimens. Anatomical Science International. 93(2). 177–187. 18 indexed citations
15.
Walter, Nicholas D., John A. Painter, Matthew Parker, et al.. (2014). Persistent Latent Tuberculosis Reactivation Risk in United States Immigrants. American Journal of Respiratory and Critical Care Medicine. 189(1). 88–95. 61 indexed citations
16.
Philip, Naomi H., Christopher P. Dillon, Annelise G. Snyder, et al.. (2014). Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling. Proceedings of the National Academy of Sciences. 111(20). 7385–7390. 222 indexed citations
17.
Dorman, Susan E., Robert Belknap, Edward A. Graviss, et al.. (2013). Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States. American Journal of Respiratory and Critical Care Medicine. 189(1). 77–87. 146 indexed citations
18.
Parker, Matthew, Xiang Chen, Armita Bahrami, et al.. (2012). Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data. Genome biology. 13(12). R113–R113. 18 indexed citations
19.
Parker, Matthew, Patrick Lu, Martin C. Woodle, et al.. (2008). MODULATION OF ISCHEMIA REPERFUSION INJURY BY THE NANOPARTICLE DELIVERY OF C3 SPECIFIC SMALL INTERFERING RNA (SIRNA). Transplantation. 86(2S). 111–112. 1 indexed citations
20.
Clark, J, Gerhardt Attard, Sameer Jhavar, et al.. (2007). Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene. 27(14). 1993–2003. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026